AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Fecal Microbiota Transplantation for Liver Failure

RecruitingNAAges 18 Years - 65 YearsAllNingbo Medical Center Lihuili Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

To investigate the safety, adverse reactions and therapeutic effects of fecal microbiota transplantation on patients with liver failure;to investigate the effect of fecal microbiota transplantation on the intestinal microecology and "gut-liver axis immune system" of liver failure, and further optimization of fecal microbiota transplantation technology.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients willing to sign informed consent * Patients aged 18-65 * According to the diagnosis standard of liver failure in the guide for diagnosis and treatment of liver failure (2018 Edition), the eligible patients are included, that is, on the basis of chronic liver disease, the syndrome with acute jaundice deepening and coagulation dysfunction as the manifestation of liver failure caused by various inducements can be combined with complications such as Hepatoencephalopathy, ascites, electrolyte disorder, infection, hepatorenal syndrome, hepatopulmonary syndrome, etc And extrahepatic organ failure. The patient's jaundice deepened rapidly, the serum TBIL โ‰ฅ 10 ร— ULN or the daily rise โ‰ฅ 17.1 ฮผ mol / L; there was bleeding, PTA โ‰ค 40% (or INR โ‰ฅ 1.5) Exclusion Criteria: * Patients with severe heart failure, COPD, cerebrovascular accident, nephrotic syndrome, etc; * Patients with gastrointestinal bleeding, pulmonary infection, septicemia, etc * Patients with liver cancer, lung cancer, lymphoma and other malignant tumors * Patients taking anticoagulants, mental diseases and immune diseases for a long time * Pregnant or lactating women.
๐Ÿ’Š

What it tests

  • fecal microbiota transplantation
๐Ÿ“

Where

1 site
Ningbo Medical Center Lihuili Hospital,Affiliated Lihuili hospital of Ningbo University
Ningbo, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy